Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: Contribution of improved cardiorespiratory fitness vs. weight loss

American Journal of Physiology - Endocrinology and Metabolism

Volumn 312, Issue 4, 2017, Pages E273-E281

  Borel, Anne Laure ^a   Nazare, Julie Anne ^b   Baillot, Aurélie ^c   Alméras, Natalie ^d,e   Tremblay, Angelo ^d,e   Bergeron, Jean ^f   Poirier, Paul ^d,e   Després, Jean Pierre ^d,e  

^a UNIV GRENOBLE ALPES   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ DU QUÉBEC EN OUTAOUAIS   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f LAVAL UNIVERSITY   (Canada)

Author keywords

Cardiometabolic risk; Lifestyle intervention; Liver fat; Physical activity; Visceral fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN B; C PEPTIDE; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; CARDIOMETABOLIC RISK; CARDIORESPIRATORY FITNESS; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; LIFESTYLE MODIFICATION; LIVER; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; HEALTH BEHAVIOR; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIFESTYLE; METABOLISM; MIDDLE AGED; OBESITY, ABDOMINAL; PHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR;

ADIPOSITY; ADULT; AGED; BODY WEIGHT; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASES; HEALTH BEHAVIOR; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIFE STYLE; LIVER; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RISK ASSESSMENT; RISK FACTORS; WEIGHT LOSS;

EID: 85016986226     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00278.2016     Document Type: Article

References (46)

1. Aadahl M, von Huth Smith L, Pisinger C, Toft UN, Glümer C, Borch-Johnsen K, Jørgensen T. Five-year change in physical activity is associated with changes in cardiovascular disease risk factors: the Inter99 study. Prev Med 48: 326–331, 2009. doi:10.1016/j.ypmed.2009.01.015.
2. Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E; Look AHEAD Adipose Research Group. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 59: 627–633, 2010. doi:10.2337/db09-1239.
3. Baillot A, Romain AJ, Boisvert-Vigneault K, Audet M, Baillargeon JP, Dionne IJ, Valiquette L, Chakra CN, Avignon A, Langlois MF. Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and metaanalysis. PLoS One 10: e0119017, 2015. doi:10.1371/journal.pone.0119017.
4. Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity. Metabolism 61: 262–272, 2012. doi:10.1016/j.metabol.2011.06.024.
5. Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) 20: 1223–1233, 2012. doi:10.1038/oby.2011.396.
6. Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med (Lond) 6: 19–25, 2006. doi:10.7861/clinmedicine.6-1-19.
7. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444: 881–887, 2006. doi:10.1038/nature05488.
8. Després JP, Ross R, Boka G, Alméras N, Lemieux I; ADAGIO-Lipids Investigators. Effect of rimonabant on the high-triglyceride/ low-HDLcholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. Arterioscler Thromb Vasc Biol 29: 416–423, 2009. doi:10.1161/ATVBAHA.108.176362.
9. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374: 1677–1686, 2009. doi:10.1016/S0140-6736(09)61457-4.
10. Ferland M, Després JP, Tremblay A, Pinault S, Nadeau A, Moorjani S, Lupien PJ, Thériault G, Bouchard C. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 61: 139–148, 1989. doi:10.1079/BJN19890104.
11. Finucane FM, Sharp SJ, Hatunic M, Sleigh A, De Lucia Rolfe E, Aihie Sayer A, Cooper C, Griffin SJ, Wareham NJ. Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals. Diabetol Metab Syndr 6: 43, 2014. doi:10.1186/1758-5996-6-43.
12. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96: 308–315, 1997. doi:10.1161/01.CIR.96.1.308.
13. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis. Diabetes Care 32: 741–750, 2009. doi:10.2337/dc08-1870.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502, 1972.
15. Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTigue K, Hames KC, Lang W, Jakicic JM. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 304: 1795–1802, 2010. doi:10.1001/jama.2010.1505.
16. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353, 1955. doi:10.1172/JCI103182.
17. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50: 1105–1112, 2009. doi:10.1002/hep.23129.
18. Keating SE, Hackett DA, George J, Johnson NA. Exercise and nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57: 157–166, 2012. doi:10.1016/j.jhep.2012.02.023.
19. 18a. Kenney WL, Humphrey RH, Mahler DA, Bryant CX; American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription (5th ed), Baltimore, MD: Williams and Wilkins, 1995.
20. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393–403, 2002. doi:10.1056/NEJMoa012512.
21. Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki- Järvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293: E1709–E1715, 2007. doi:10.1152/ajpendo.00444.2007.
22. Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, Wagenknecht LE, Pi-Sunyer FX, Kahn SE, Clark JM; Fatty Liver Subgroup of the Look AHEAD Research Group. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 33: 2156–2163, 2010. doi:10.2337/dc10-0856.
23. Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B, Dagenais GR, Després JP. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol 23, Suppl B: 23B–31B, 2007. doi:10.1016/S0828-282X(07)71007-3.
24. Liu J, Sui X, Lavie CJ, Zhou H, Park YM, Cai B, Liu J, Blair SN. Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men. J Am Coll Cardiol 64: 1245–1253, 2014. doi:10.1016/j.jacc.2014.06.1184.
25. Look AHEAD Research Group, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 30: 1374–1383, 2007. doi:10.2337/dc07-0048.
26. Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369: 145–154, 2013. doi:10.1056/NEJMoa1212914.
27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462–1470, 1999. doi:10.2337/diacare.22.9.1462.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419, 1985. doi:10.1007/BF00280883.
29. Nazare JA, Smith J, Borel AL, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP. Changes in both global diet quality and physical activity level synergistically reduce visceral adiposity in men with features of metabolic syndrome. J Nutr 143: 1074–1083, 2013. doi:10.3945/jn.113.175273.
30. Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, Tan CE, Wittchen HU, Matsuzawa Y, Kadowaki T, Ross R, Brulle- Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP; INSPIRE ME IAA Investigators. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 115: 307–315, 2015. doi:10.1016/j.amjcard.2014.10.039.
31. Office of Disease Prevention and Health Promotion. Physical Activity Guidelines for Americans. Washington, DC: US Department of Health and Human Services. https://health.gov/PAGuidelines/ [2008].
32. Paré A, Dumont M, Lemieux I, Brochu M, Alméras N, Lemieux S, Prud’homme D, Després JP. Is the relationship between adipose tissue and waist girth altered by weight loss in obese men? Obes Res 9: 526–534, 2001. doi:10.1038/oby.2001.69.
33. Payne WR, Walsh KJ, Harvey JT, Livy MF, McKenzie KJ, Donaldson A, Atkinson MG, Keogh JB, Moss RS, Dunstan DW, Hubbard WA. Effect of a low-resource-intensive lifestyle modification program incorporating gymnasium-based and home-based resistance training on type 2 diabetes risk in Australian adults. Diabetes Care 31: 2244–2250, 2008. doi:10.2337/dc08-0152.
34. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499–511, 2003. doi:10.1161/01.CIR.0000052939.59093.45.
35. Poirier P, Lemieux I, Mauriège P, Dewailly E, Blanchet C, Bergeron J, Després JP. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension 45: 363–367, 2005. doi:10.1161/01.HYP.0000155463.90018.dc.
36. Provyn S, Clarys JP, Wallace J, Scafoglieri A, Reilly T. Quality control, accuracy, and prediction capacity of dual energy X-ray absorptiometry variables and data acquisition. J Physiol Anthropol 27: 317–323, 2008. doi:10.2114/jpa2.27.317.
37. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 47: 739–744, 1987. doi:10.3109/00365518709168939.
38. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133: 92–103, 2000. doi:10.7326/0003-4819-133-2-200007180-00008.
39. No authors listed. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. Obes Res 6, Suppl 2: 51S–209S, 1998.
40. Sjöström L, Kvist H, Cederblad A, Tylén U. Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium. Am J Physiol Endocrinol Metab 250: E736–E745, 1986.
41. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363: 1341–1350, 2010. doi:10.1056/NEJMra0912063.
42. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 56: 255–266, 2012. doi:10.1016/j.jhep.2011.06.010.
43. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343–1350, 2001. doi:10.1056/NEJM200105033441801.
44. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 17: 187–196, 1993.
45. Yates T, Davies M, Gorely T, Bull F, Khunti K. Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 32: 1404–1410, 2009. doi:10.2337/dc09-0130.
46. Yoshimura E, Kumahara H, Tobina T, Matsuda T, Ayabe M, Kiyonaga A, Anzai K, Higaki Y, Tanaka H. Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity. J Obes 2014: 197216, 2014. doi:10.1155/2014/197216.